bioRxiv Science⌕ Search

bioRxiv · 10.64898/2026.04.10.717641

Multi-objective Engineering of Trimethylamine Monooxygenase for Improved Thermostability and Cofactor Use

Abstract

Trimethylamine (TMA) is a major contributor to undesirable odours in protein hydrolysates derived from marine by-products, limiting their industrial use. Flavin-containing monooxygenases (FMOs) catalyse the conversion of TMA to the odourless trimethylamine N-oxide (TMAO); however, industrial applications demand enzymes that are both thermally stable and compatible with cost-effective cofactors. A thermostable variant of the Methylophaga aminisulfidivorans FMO (mFMO_20) can function at elevated temperatures but depends exclusively on the expensive and unstable cofactor NADPH. In this study, we investigated whether it is possible to simultaneously enhance thermostability and NADH compatibility using a multi-objective engineering strategy. We first targeted residues in the cofactor binding site of mFMO_20 to restore NADH activity, which had been completely lost despite the wild type enzyme being naturally active with both cofactors. Variants derived from the thermostable scaffold partially recovered NADH activity but showed reduced NADPH activity. Given the wild types inherent NADH compatibility, we next pursued a stability-improvement approach, introducing highly conserved stabilizing mutations. This preserved cofactor competence but produced only modest improvements in thermostability. Finally, by combining physical, evolutionary, and statistical metrics, we obtained variants that retained higher NADPH activity after heat treatment than any previously reported thermostable mutants, while a subset also retained measurable NADH activity before heat treatment. These findings show that combining complementary scoring strategies helps navigate the trade-off between stability and activity; while, robust NADH function under thermal stress remains elusive, with only one variant retaining detectable NADH activity after heat treatment, the results provide valuable insight into the underlying constraints linking stability and cofactor usage and highlights possible directions for engineering FMOs with both enhanced thermostability and cofactor compatibility. Author summaryIn this work, we aimed to improve an enzyme that could be useful in industrial applications but is limited by two common constraints: poor stability at high temperatures and dependence on an expensive cofactor. To make the enzyme more suitable for large-scale applications, we sought to engineer variants that are both more thermostable and compatible with a cheaper cofactor, NADH. For enzyme engineering, we used a strategy that balances several properties rather than prioritizing a single trait. We combined tools that capture evolutionary patterns, protein physics, and AI-based predictions to explore which mutations might provide the right combination of stability and function. Through this approach, we obtained variants with improved heat resistance and higher cofactor activity retention.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Xiang, R., Floor, M., Ree, R., Canellas-Sole, A., Puntervoll, P., Roda, S., Elin Kjaereng Bjerga, G., Guallar, V.. 2026-04-12. Multi-objective Engineering of Trimethylamine Monooxygenase for Improved Thermostability and Cofactor Use. https://doi.org/10.64898/2026.04.10.717641

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Engineered Miniature ParTasR Enables Efficient PAMless Genome Editing

TIGR-Tas system holds great promise for genome-engineering applications owing to its compact size and PAMless targeting capability. However, its low editing efficiency in mammalian cells severely limits its broader utility. Here, we engineered a highly active variant of ParTasR, termed eTasR, through structure-guided rational design of ParTasR combined with fusion to the exonuclease TREX2. eTasR increased mammalian editing efficiency from the original 4.29% to 48.94% with an average 26.52-fold increase, significantly surpassing the efficiency of SpRY, a reported version of PAM-free nuclease. More importantly, single-AAV delivery enabled efficient Hpd disruption in vivo, resulting in robust phenotypic rescue. Thus, eTasR provides a compact, PAMless and highly efficient platform for genome editing and therapeutic applications.

molecular biology↗

Enhancing pancreatic islet cell survival via NMDAR antagonist-driven ROR1 activation as revealed by phosphoproteomics

NMDA receptors (NMDARs) control function and survival not only of neurons, but also of insulin-producing pancreatic beta cells. Since insufficient insulin secretion and beta cell death are key events during diabetes development, targeting NMDARs offers a therapeutic approach. Specifically, the NMDAR antagonist dextrorphan (DXO) increases glucose-stimulated insulin secretion in clinical trials. Furthermore, treatment with DXO or optimized DXO derivatives prevents pancreatic islet cell death upon diabetogenic insults. Nonetheless, the signaling pathways induced by NMDAR inhibition are poorly understood. Here, we use complementary approaches, phosphoproteomics and tyrosine kinase profiling, to demonstrate that DXO and its derivatives rapidly regulate multiple intracellular signaling clusters, including mTOR and ERK signaling, in pancreatic islets. Notably, mTOR inhibition, but not ERK inhibition, is sufficient to negate DXO's protective effects. Further, we show that activation of Receptor Tyrosine Kinase-like Orphan Receptor 1 (ROR1) is a universal event upon NMDAR inhibition in islets. Simultaneous knockdown of Ror1/ROR1 and its paralogue Ror2/ROR2 compromises the viability of both mouse and human islets, highlighting the ROR1/2 signaling axis as a promising avenue for enhancing beta cell survival.

molecular biology↗

An ssRNA Phage Single-gene Lysis Protein Targeting MraY Reveals Convergent Evolution Across the RNA-DNA Phage Boundary

Small lytic phages of the ssRNA Leviviricetes and ssDNA Microviricetes achieve host lysis by expression of a single protein, designated as an Sgl protein. Four ssRNA Sgls have been shown to inhibit steps in peptidoglycan biosynthesis: three target MurJ, the Lipid II flippase, and one targets MurA, the committed step of the pathway. A fifth Sgl, the E protein of the canonical ssDNA microvirus {varphi}X174, inhibits MraY, which catalyzes the synthesis of the first lipid-linked intermediate. This inhibition requires SlyD, a cytoplasmic FKBP-type peptidyl-prolyl cis-trans isomerase. The Sgl of the Caulobacter ssRNA phage {varphi}Cb5 (Cebevirus halophobicum) has not been characterized. Here, we present physiological evidence that Sgl{varphi}Cb5 targets MraY. Moreover, we show that, despite the absence of detectable sequence similarity, Sgl{varphi}Cb5 shares several features with the {varphi}X174 E protein, including the distribution of hydrophobic and charged residues, a proposed N-out, C-in membrane topology, and retention of lytic activity in an Sgl{varphi}Cb5 -LacZ fusion. Furthermore, expression of the Caulobacter cytoplasmic FKBP-type peptidyl-prolyl cis-trans isomerase CC2799 enhances Sgl{varphi}Cb5 -mediated lysis in E. coli. These parallels between Sgl function in a DNA phage and an RNA phage either represent remarkably consonant convergent evolution or some evolutionary cross-over event for which there is currently no precedent.

molecular biology↗